Amenorrhea: Clinical Trials

14 trials for Amenorrhea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 recruiting, 1 terminated, 1 unknown. 14 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 214Completed 10, Recruiting 2, Terminated 1, Unknown 1
Phase 12Completed 1, Terminated 1
Phase 32Completed 1, Recruiting 1

Follow Amenorrhea: new trials by email Literature Review of Amenorrhea trials Research Report on Amenorrhea

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
Mibavademab, Placebo - Functional Hypothalamic Amenorrhea, FHA
Phase 2RecruitingRegeneron Pharmaceuticals342026-03-112026-11-04
The Role of Estrogen in the Neurobiology of Eating Disorders
17-β estradiol transdermal patches, Placebo Patch, Micronized progesterone 200 MG - Eating Disorders, Hypoestrogenemia
Phase 2CompletedMassachusetts General Hospital1222019-06-132026-11-05
Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women
Autologous PRP intra ovarian infusion, Autologous PFP intra ovarian infusion - Infertility, Female, Anovulatory Infertility
Phase 2 / Phase 3RecruitingGenesis Athens Clinic1002019-05-212026-07-08
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
17beta Estradiol, Transdermal placebo patch, Progesterone - Estrogen Deficiency, Cardiovascular Disease (CVD)
Phase 2CompletedCedars-Sinai Medical Center292017-01-012025-03-13
Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women
Flutamide, Placebo - Polycystic Ovary Syndrome (PCOS)
Phase 2CompletedUniversity of California, Los Angeles232013-04-012025-01-10
Determination of the Lowest, Safe and Effective Dose of Proellex
Proellex - Amenorrhea
Phase 1 / Phase 2CompletedRepros Therapeutics Inc.522010-08-012014-07-28
Study of Leptin for the Treatment of Hypothalamic Amenorrhea
r-metHuLeptin, Oral Contraceptive Pills (OCPs), Placebo - Amenorrhea
Phase 2CompletedBeth Israel Deaconess Medical Center202010-04-012017-05-17
Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones
Lo-Ovral Oral Contraceptive Pills, Placebo - sugar pill - Aplastic Anemia, Menorrhagia
Phase 1 / Phase 2TerminatedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)12007-11-012013-07-19
A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
DR-2021a, DR-2021b, DR-2021c - Amenorrhea
Phase 2CompletedDuramed Research1802005-09-012014-07-30
Effects of Anorexia Nervosa on Bone Mass in Adolescents
Physiologic Estrogen/progesterone, Placebo - Anorexia Nervosa
Phase 2 / Phase 3CompletedMassachusetts General Hospital1102003-07-012021-11-02
GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients
Leuprolide Acetate, Questionnaire, Hematopoietic Stem Cell Transplantation - Amenorrhea, Premature Ovarian Failure
Phase 2CompletedM.D. Anderson Cancer Center602002-11-012013-07-09
A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women
Asoprisnil/Premarin - Postmenopause
Phase 2CompletedAbbott182001-04-012008-05-29
A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women
Asoprisnil/Premarin, Placebo and Premarin - Amenorrhea, Postmenopause
Phase 2CompletedAbbott1052000-09-012008-05-29
Pulsatile GnRH in Anovulatory Infertility
GnRH, Pump - Hypogonadotropic Hypogonadism, Amenorrhea
Phase 2UnknownMassachusetts General Hospital2701989-01-012017-07-12

Narrower conditions

Anorexia Nervosa (2)  ·  Infertility, Female (2)  ·  Anemia, Aplastic (1)  ·  Anovulation (1)  ·  Cardiovascular Diseases (1)  ·  Feeding and Eating Disorders (1)  ·  Hirsutism (1)  ·  Hyperandrogenism (1)  ·  Hypogonadism (1)  ·  Infertility (1)  ·  Kallmann Syndrome (1)  ·  Menorrhagia (1)  ·  Oligomenorrhea (1)  ·  Polycystic Ovary Syndrome (1)

Broader conditions

Menstruation Disturbances (14)  ·  Pathologic Processes (14)  ·  Pathological Conditions, Signs and Symptoms (14)  ·  Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Genital Diseases (6)  ·  Urogenital Diseases (6)  ·  Genital Diseases, Female (5)  ·  Endocrine System Diseases (3)  ·  Gonadal Disorders (3)  ·  Adnexal Diseases (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Disorders of Sex Development (2)  ·  Infertility (2)

Interventions

Progesterone (4)  ·  Estrogens, Conjugated (USP) (2)  ·  asoprisnil (2)  ·  Estradiol (1)  ·  Flutamide (1)  ·  Gonadotropin-Releasing Hormone (1)  ·  Hematopoietic Stem Cell Transplantation (1)  ·  Leuprolide (1)  ·  Stem Cell Transplantation (1)  ·  Surveys and Questionnaires (1)  ·  metreleptin (1)  ·  recombinant methionyl human leptin (1)  ·  telapristone acetate (1)

Sponsors

Massachusetts General Hospital (3)  ·  Abbott (2)  ·  Beth Israel Deaconess Medical Center (1)  ·  Cedars-Sinai Medical Center (1)  ·  Duramed Research (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Genesis Athens Clinic (1)  ·  M.D. Anderson Cancer Center (1)  ·  Regeneron Pharmaceuticals (1)  ·  Repros Therapeutics Inc. (1)  ·  University of California, Los Angeles (1)

Countries

United States (11)  ·  Greece (1)

Top investigators

Agni Pantou, MD (1)  ·  Chrisandra Shufelt, MD (1)  ·  Christos S Mantzoros, MD, ScD (1)  ·  Daniel Dumesic, MD (1)  ·  Janet E Hall, M.D. (1)  ·  Laura M Sterling, MD (1)  ·  Madhusmita Misra, M.D., M.P.H. (1)  ·  Madhusmita Misra, MD (1)  ·  Naoto Ueno, MD, PhD (1)  ·  Noel Bairey-Merz, MD (1)  ·  Pamela Stratton, MD (1)

Results publications

PMID 21464293, PMID 21593494, PMID 21660636, PMID 21698665, PMID 21741057, PMID 22282904, PMID 22728230, PMID 23341491, PMID 23382191, PMID 24021517, PMID 24703486, PMID 25148234, PMID 32034419, PMID 33045195, PMID 33051459, PMID 36400597, PMID 37610989, PMID 39097160, PMID 40294815

NIH funding

M01RR001032 (1), R01DK062249 (1), R01MH116205 (1), R34HD048526 (1), U54HD028138 (1)